Rock Springs Capital Management’s Clementia Pharmaceuticals Inc. CMTA Stock Holding History

Rock Springs Capital Management’s Portfolio CMTA Stock Details CMTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-275,000	Closed	-$7.18M	–	140
2019 Q1	$7.18M	Hold	275,000	–	–	0.28%	94
2018 Q4	$3.23M	Sell	275,000 -70,000	-20%	-$871K	0.15%	113
2018 Q3	$3.85M	Hold	345,000	–	–	0.14%	126
2018 Q2	$4.54M	Hold	345,000	–	–	0.17%	121
2018 Q1	$5.23M	Hold	345,000	–	–	0.22%	115
2017 Q4	$6.55M	Hold	345,000	–	–	0.3%	93
2017 Q3	$5.83M	Buy	+345,000	New	+$5.64M	0.27%	98

Rock Springs Capital Management's CMTA Position: Q2 2019 in Review

Rock Springs Capital Management sold out of Clementia Pharmaceuticals Inc. (CMTA) in Q2 2019, closing a stake of 275,000 shares — an estimated $7.18M sold.

Rock Springs Capital Management first reported a position in CMTA in Q3 2017 and held it in 7 quarters. The position peaked at $7.18M in Q1 2019. 0 funds tracked by Wall St. Rank hold CMTA as of Q2 2019.

Rock Springs Capital Management reported no remaining Clementia Pharmaceuticals Inc. position as of Q2 2019 after selling out during the quarter.
Rock Springs Capital Management sold 275,000 Clementia Pharmaceuticals Inc. shares in Q2 2019, an estimated $7.18M.
Rock Springs Capital Management first reported a position in Clementia Pharmaceuticals Inc. in Q3 2017 and held it in 7 quarters.
Rock Springs Capital Management's Clementia Pharmaceuticals Inc. position peaked at $7.18M in Q1 2019.
0 funds tracked by Wall St. Rank held Clementia Pharmaceuticals Inc. as of Q2 2019.

Based on Rock Springs Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.